[1] LÖSCHER W. Basic pharmacology of valproate: a review after 35 years of clinical use for the treatment of epilepsy[J]. CNS Drugs,2002,16(10):669-694.
[2] FERREY A E, GEULAYOV G, CASEY D, et al. Relative toxicity of mood stabilisers and antipsychotics: case fatality and fatal toxicity associated with self-poisoning[J]. BMC Psychiatry,2018,18(1):399.
[3] 喻东山, 李广录, 汪春运. 丙戊酸钠的不良反应研究新进展[J]. 国际神经病学神经外科学杂志, 2005, 32(4):319-321.
[4] DUPUIS R E, LICHTMAN S N, POLLACK G M. Acute valproic acid overdose. Clinical course and pharmacokinetic disposition of valproic acid and metabolites[J]. Drug Saf,1990,5(1):65-71.
[5] 孙利伟, 闫红月. 荧光偏振免疫法测定丙戊酸钠血清药物浓度[J]. 中国实用医药, 2010, 5(29):127-128.
[6] 黄凤娇, 李继洪, 唐敦立, 等. 丙戊酸钠与双丙戊酸钠的毒性比较[J]. 中国药物警戒, 2012, 9(1):7-9.
[7] 中国医师协会急诊医师分会, 中国毒理学会中毒与救治专业委员会. 急性中毒诊断与治疗中国专家共识[J]. 中华急诊医学杂志, 2016, 25(11):1361-1375.
[8] 戈文兰, 王广基, 孙建国, 等. 丙戊酸钠缓释片及其人体生物利用度的研究[J]. 中国药科大学学报, 2000, 31(6):422.
[9] GHANNOUM M, LALIBERTÉ M, NOLIN T D, et al. Extracorporeal treatment for valproic acid poisoning: systematic review and recommendations from the EXTRIP workgroup[J]. Clin Toxicol (Phila),2015,53(5):454-465.
[10] MOINHO R, DIAS A, ESTANQUEIRO P, et al. Overdose with antiepileptic drugs: the efficacy of extracorporeal removal techniques[J]. BMJ Case Rep,2014,2014:bcr2014207761.
[11] DORÉ M, SAN JUAN A E, FRENETTE A J, et al. Clinical importance of monitoring unbound valproic acid concentration in patients with hypoalbuminemia[J]. Pharmacotherapy,2017,37(8):900-907.
[12] 史道华, 邓婕, 连秋燕. 血浆蛋白含量与丙戊酸游离药物浓度的相关性[J]. 中国临床药理学杂志, 2014, 30(3):188-189,201.
[13] 史纳. 醒脑静与门冬氨酸鸟氨酸联合用药方案治疗肝性脑病的临床研究[J]. 中国现代药物应用, 2020, 14(16):156-158.
[14] 曹芳, 张广文, 闫亚平. 乳果糖口服溶液联合注射用门冬氨酸鸟氨酸治疗肝性脑病的临床效果及对神经毒性物质、炎症因子水平的影响[J]. 临床医学研究与实践, 2020, 5(36):14-16.